Related Experiment Video

Updated: Mar 29, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

7.6K

Turning killer into cure -- the story of oncolytic herpes simplex viruses

Shaun Xiaoliu Zhang1

  • 1Department of Biology and Biochemistry and Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX 77004, USA.

Discovery Medicine
|December 10, 2015
PubMed

Insights

Cancer virotherapy harnesses viruses to selectively destroy cancer cells. Herpes simplex virus (HSV)-based oncolytic viruses show promise, with recent trials indicating significant benefits for melanoma patients.

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Viruses naturally kill host cells and can replicate rapidly.
  • Cancer virotherapy modifies viruses to target and destroy malignant cells specifically.
  • The field of virotherapy has advanced significantly in recent years.

Purpose of the Study:

  • To review the development and progress of herpes simplex virus (HSV)-based oncolytic viruses.
  • To discuss the potential of virotherapy for cancer treatment.
  • To highlight recent advancements and future directions in HSV-based oncolytic virotherapy.

Main Methods:

  • Review of historical data and recent clinical trial results.
  • Focus on herpes simplex virus (HSV) as a platform for oncolytic viruses.
  • Analysis of T-VEC (HSV-based oncolytic virus) phase III trial data in melanoma.

Main Results:

  • Herpes simplex virus (HSV)-based oncolytic viruses demonstrate specificity for malignant cells.
  • Phase III trial data for T-VEC in melanoma patients show substantial improvements in objective and durable responses.
  • These results suggest potential FDA approval for clinical use in the near future.

Conclusions:

  • Oncolytic virotherapy, particularly using HSV, is a promising cancer treatment strategy.
  • Recent clinical data support the efficacy of HSV-based oncolytic viruses in specific cancers like melanoma.
  • Further research and development hold potential for improving HSV-based oncolytic virotherapy.

More Related Videos

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

10.0K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.1K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
15.8K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
24